Interaction between herpes simplex virus type 1 IE63 protein and cellular protein p32

Journal of Virology

Volumn 74, Issue 23, 2000, Pages 11322-11328

  Bryant, H E ^a   Matthews, D A ^a   Wadd, S ^a   Scott, J E ^a   Kean, J ^a   Graham, S ^a   Russell, W C ^a   Barklie Clements, J ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CASEIN KINASE II; CELL PROTEIN; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN; IMMEDIATE EARLY PROTEIN; IMMEDIATE EARLY PROTEIN 63; MESSENGER RNA; PROTEIN P32; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; GENE FUNCTION; HELA CELL; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN CELL; IMMEDIATE EARLY GENE; IMMUNOPRECIPITATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RNA SPLICING;

AMINO ACID SEQUENCE; CARRIER PROTEINS; CASEIN KINASE II; GENE PRODUCTS, REV; HELA CELLS; HERPESVIRUS 1, HUMAN; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEIN K; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEINS; HUMANS; IMMEDIATE-EARLY PROTEINS; MITOCHONDRIAL PROTEINS; MOLECULAR SEQUENCE DATA; NUCLEAR PROTEINS; PRECIPITIN TESTS; PROTEIN-SERINE-THREONINE KINASES; RIBONUCLEOPROTEINS; RNA SPLICING;

EID: 0034467101     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.74.23.11322-11328.2000     Document Type: Article

References (54)

1. Characterization of herpes simplex 1 α proteins 0, 4, and 27 with monoclonal antibodies
2. Induction of immunoglobulin G Fc receptors by recombinant vaccinia viruses expressing glycoproteins E and I of herpes simplex type 1
3. Open reading frame P - A herpes simplex virus gene repressed during productive infection encodes a protein that binds a splicing factor and reduces synthesis of viral proteins made from spliced mRNA
4. The multifunctional herpes simplex virus IE63 protein interacts with heterogeneous ribonucleoprotein K and with casein kinase 2
5. Physical association between the EBV protein EBNA 1 and P32/TAP/hyaluronectin
6. Herpes simplex virus ICP27 induces cytoplasmic accumulation of unspliced polyadenylated α-globin pre-mRNA in infected HeLa cells
7. Posttranscriptional regulation by the HIV-1 Rev protein
8. Molecular cloning of human fibroblast hyaluronic acid-binding protein confirms its identity with p32, a protein co-purified with splicing factor SF2
9. Herpes simplex virus type 1 encodes two Fc receptors which have different binding characteristics for monomeric immunoglobulin G (IgG) and IgG complexes
10. Regulated tissue-specific expression of antagonist pre-mRNA splicing factors
11. The herpes simplex virus regulatory protein ICP27 contributes to the decrease in cellular mRNA levels during infection
12. Herpes simplex virus inhibits host cell splicing, and regulatory protein ICP27 is required for this effect
13. Crystal structure of human p32 a doughnut-shaped acidic mitochondrial matrix protein
14. Herpes simplex virus immunoglobulin G Fc receptor activity depends on a complex of two viral glycoproteins, gE and gI
15. The essential pre-mRNA splicing factor SF2 influences 5′ splice site selection by activating proximal sites
16. Purification and characterisation of SF2, a human pre-mRNA splicing factor
17. Cellular protein modulates effects of human immunodeficiency virus type 1 Rev
18. Converting a eukaryotic transcriptional inhibitor into an activator
19. Adenovirus core protein V interacts with p32 - A protein which is associated with both the mitochondria and the nucleus
20. Two members of a conserved family of phosphoproteins are involved in pre-mRNA splicing
21. Herpes simplex virus type 1 ICP27 deletion mutants exhibit altered patterns of transcription and are DNA deficient
22. Regulation of herpes simplex virus type 1 poly(A) site usage and the action of the immediate-early protein IE63 in the early-late switch
23. The repressing and enhancing functions of the herpes simplex virus regulatory protein ICP27 map to C-terminal regions and are required to modulate viral gene expression very early in infection
24. The herpes simplex virus immediate-early protein ICP27 shuttles between nucleus and cytoplasm
25. Regulation of mammalian spliceosome assembly by a protein phosphorylation mechanism
26. Ser/Thr-specific protein phosphatases are required for both catalytic steps of pre-mRNA splicing
27. Protein phosphorylation and the nuclear organisation of pre-mRNA splicing
28. p32 protein, a splicing factor 2-associated protein, is localized in mitochondrial matrix and is functionally important in maintaining oxidative phosphorylation
29. The C1q-binding cell membrane proteins cC1q-R and gC1q-R are released from activated cells: Subcellular distribution and immunochemical characterisation
30. The splicing factor associated protein p32 regulates RNA splicing by inhibiting ASF/SF2 RNA binding and phosphorylation
31. A herpes simplex virus type 1 immediate-early gene product, IE63, regulates small nuclear ribonucleoprotein distribution
32. Herpes simplex virus type 1 immediate-early protein 1E63 shuttles between nuclear compartments and the cytoplasm
33. Posttranscriptional regulation in herpes simplex virus
34. Herpes simplex virus type 1 protein IE63 affects the nuclear export of virus intron-containing transcripts
35. 134.5 gene and may account for the attenuation of the mutant virus
36. Gene-specific transactivation by herpes simplex virus type 1 α protein ICP27
37. Genetic evidence for two distinct transactivation functions of the herpes simplex virus α protein ICP27
38. Herpes simplex virus α protein ICP27 possesses separable positive and negative regulatory activities
39. Herpes simplex virus type 1 ICP27 is an essential regulatory protein
40. ICP27 mediates HSV RNA export by shuttling through a leucine-rich nuclear export signal and binding viral intronless RNAs through an RGG motif
41. The herpes simplex virus type 1 regulatory protein ICP27 coimmunoprecipitates with anti-Sm anti-serum, and the C terminus appears to be required for this interaction
42. The C-terminal repressor region of herpes simplex virus type 1 ICP27 is required for the redistribution of small nuclear ribonucleoprotein particles and splicing factor SC35; however, these alterations are not sufficient to inhibit host cell splicing
43. A herpesvirus regulatory protein appears to act post-transcriptionally by affecting mRNA processing
44. The lamin B receptor-associated protein p34 shares sequence homology and antigenic determinants with the splicing factor 2-associated protein p32
45. Evidence that the herpes simplex virus immediate-early protein ICP27 acts post-transcriptionally during infection to regulate gene expression
46. Shuttling of the herpes simplex virus type 1 regulatory protein ICP27 between the nucleus and the cytoplasm mediates the expression of late proteins
47. Herpesvirus mRNAs are sorted for export via Crm-1 dependent and -independent pathways
48. Inhibition of HSV-1 DNA replication by mutant forms of the origin binding protein
49. In vitro interaction between human immunodeficiency virus type 1 Rev protein and splicing factor ASF/SF2-associated protein p32
50. Description of an I1-1-responsive kinase that phosphorylates the K-protein - Enhancement of phosphorylation by selective DNA and RNA motifs
51. p32/Tap, a cellular protein that interacts with EBNA-1 of Epstein-Barr virus
52. In vitro interaction of the human immunodeficiency virus type 1 Tat transactivator and the general transcription factor TFIIB with the cellular protein TAP
53. Molecular cloning and characterization of a cellular protein that interacts with the human immunodeficiency virus type 1 Tat transactivator and encodes a strong transcriptional activation domain
54. Self-interaction of the herpes simplex virus type 1 regulatory protein ICP 27